Edaravone offers neuroprotection for acute diabetic stroke patients
ConclusionEdaravone represents a promising neuroprotectant against cerebral ischemic injury in diabetic patients.
Source: Irish Journal of Medical Science - Category: Journals (General) Source Type: research
More News: Aspirin | Atorvastatin Calcium | Biomedical Science | Diabetes | Endocrinology | Epilepsy | General Medicine | Hemorrhagic Stroke | Ischemic Stroke | Lipitor | Neurology | Neuroscience | Science | Statin Therapy | Stroke | Study | Zivast